Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tonix Pharmaceuticals

13.02
-1.6100-11.00%
Post-market: 13.480.4608+3.54%19:59 EST
Volume:2.11M
Turnover:29.29M
Market Cap:72.79M
PE:-1.68
High:15.30
Open:14.60
Low:12.66
Close:14.63
Loading ...

Tonix Pharmaceuticals Holding Corp reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
12 Nov 2024

Tonix Pharmaceuticals Q3 2024 GAAP EPS $(0.23) Beats $(2.93) Estimate, Sales $2.80M Miss $3.08M Estimate

Benzinga
·
12 Nov 2024

Tonix Pharmaceuticals reports Q3 EPS (23c), consensus ($2.93)

TIPRANKS
·
12 Nov 2024

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights

GlobeNewswire
·
12 Nov 2024

Tonix Pharmaceuticals Holding Corp expected to post a loss of $2.93 a share - Earnings Preview

Reuters
·
06 Nov 2024

Tonix Pharma Partners for Vaccine Clinical Trial

TipRanks
·
05 Nov 2024

BRIEF-Tonix Pharmaceuticals And Kenya Medical Research Institute To Design, Plan And Seek Regulatory Approval For Phase I Clinical Study Of TNX-801 For Mpox In Kenya

Reuters
·
04 Nov 2024

Tonix Pharmaceuticals announces research agreement with KEMRI

TIPRANKS
·
04 Nov 2024

Tonix Pharmaceuticals Holding Corp - to Sponsor, Kemri to Lead Clinical Trial for Tnx-801

THOMSON REUTERS
·
04 Nov 2024

Tonix Pharmaceuticals Holding Corp - to Test Tnx-801 Vaccine for Mpox in Kenya

THOMSON REUTERS
·
04 Nov 2024

Tonix Pharmaceuticals Announces Research Agreement With Kenya Medical Research Institute (Kemri) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of Tnx-801 for Mpox in Kenya

THOMSON REUTERS
·
04 Nov 2024

Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya

GlobeNewswire
·
04 Nov 2024

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine Tnx-801 at World Vaccine Congress-Europe 2024

THOMSON REUTERS
·
01 Nov 2024

Tonix Pharmaceuticals Holding Corp - Tnx-801 Shows Tolerability and No Spreading in Immunocompromised Animals

THOMSON REUTERS
·
01 Nov 2024

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024

GlobeNewswire
·
01 Nov 2024

Tonix Pharmaceuticals to Present at BIO-Europe® 2024

GlobeNewswire
·
29 Oct 2024